Literature DB >> 1360256

Combined invasive and noninvasive study of left ventricular systolic and diastolic function following acute administration of cicloprolol to subjects with normal cardiac function.

L Bonandi1, M Metra, L Niccoli, F Ettori, S Nodari, L Dei Cas, O Visioli.   

Abstract

Cicloprolol is a new beta-blocking agent with high selectivity for beta 1 receptors and high intrinsic sympathomimetic activity. We studied the acute hemodynamic effects of cicloprolol in nine subjects with no evidence of left ventricular dysfunction who underwent cardiac catheterization for the evaluation of chest pain. All patients had normal coronary angiography and left ventriculography. Left ventricular pressure was determined throughout the cardiac cycle using a Millar 8Fr Minotip catheter; an echocardiogram, phonocardiogram, and ECG were simultaneously recorded to obtain left ventricular pressure-diameter loops. All the measurements were repeated before and after the intravenous administration of cicloprolol. Cicloprolol was administered at increasing doses of 0.05, 0.10, and 0.25 mg/kg until a cardiac output increase of at least 15% over basal values was achieved. A decrease of mean arterial pressure or cardiac output after cicloprolol was not observed in any patient. Cicloprolol administration significantly increased cardiac output (24%), stroke volume (22%), and peak positive dP/dt (25%); no significant changes in heart rate, systemic blood pressure, right atrial pressure, or pulmonary artery pressures were observed. No significant change in the echocardiographic parameters occurred. Among the indices of left ventricular diastolic function, the time constant of isovolumetric relaxation was significantly decreased (-43%) after cicloprolol; moreover, the left ventricular pressure-diameter loop in the protodiastolic phase was shifted to the left following cicloprolol infusion. This study confirms that in subjects with normal left ventricular function cicloprolol can improve resting left ventricular systolic function, and it shows that this action can also be attended by a more rapid isovolumetric relaxation, similar to what has been observed with other sympathomimetic amines.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1360256     DOI: 10.1007/bf00055610

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  7 in total

1.  Comparative effects of atenolol and cicloprolol on cardiac performance in coronary heart disease.

Authors:  B Silke; S P Verma; S K Sharma; M A Frais; G Reynolds; S H Taylor
Journal:  J Cardiovasc Pharmacol       Date:  1989-01       Impact factor: 3.105

2.  Wall stress and patterns of hypertrophy in the human left ventricle.

Authors:  W Grossman; D Jones; L P McLaurin
Journal:  J Clin Invest       Date:  1975-07       Impact factor: 14.808

3.  Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.

Authors:  P E Hicks; I Cavero; P Manoury; F Lefevre-Borg; S Z Langer
Journal:  J Pharmacol Exp Ther       Date:  1987-09       Impact factor: 4.030

4.  Double-blind placebo-controlled comparison of digoxin and xamoterol in chronic heart failure. The German and Austrian Xamoterol Study Group.

Authors: 
Journal:  Lancet       Date:  1988-03-05       Impact factor: 79.321

5.  Haemodynamic dose-response actions of cicloprolol in left ventricular dysfunction due to ischaemic heart disease.

Authors:  B Silke; S P Verma; S K Sharma; W Baig; N C Jackson; G Reynolds; M A Frais; S H Taylor
Journal:  Int J Cardiol       Date:  1987-11       Impact factor: 4.164

6.  The differential effects of positive inotropic and vasodilator therapy on diastolic properties in patients with congestive cardiomyopathy.

Authors:  J D Carroll; R M Lang; A L Neumann; K M Borow; S I Rajfer
Journal:  Circulation       Date:  1986-10       Impact factor: 29.690

7.  Comparisons of the inotropic effects of the beta 1-adrenoceptor partial agonists SL 75.177.10 and ICI 118,587 with digoxin on the intact canine heart.

Authors:  H Pouleur; H Van Mechelen; H Balasim; M F Rousseau; A A Charlier
Journal:  J Cardiovasc Pharmacol       Date:  1984 Jul-Aug       Impact factor: 3.105

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.